Literature DB >> 31644503

Pharmacokinetic and Pharmacodynamic Effects of Metronidazole May Account for the Superior Efficacy of Multidose Therapy Among Women With Trichomoniasis.

Davey Legendre, Christina A Muzny1, Patricia Kissinger2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31644503      PMCID： PMC9575620          DOI： 10.1097/OLQ.0000000000001059

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   3.868


× No keyword cloud information.
  10 in total

1.  Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses.

Authors:  B A Wood; A M Monro
Journal:  Br J Vener Dis       Date:  1975-02

2.  A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.

Authors:  Patricia Kissinger; Leandro Mena; Judy Levison; Rebecca A Clark; Megan Gatski; Harold Henderson; Norine Schmidt; Susan L Rosenthal; Leann Myers; David H Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12-15       Impact factor: 3.731

3.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

Review 4.  Single-Dose Compared With Multidose Metronidazole for the Treatment of Trichomoniasis in Women: A Meta-Analysis.

Authors:  Katharine Howe; Patricia J Kissinger
Journal:  Sex Transm Dis       Date:  2017-01       Impact factor: 2.830

Review 5.  Mechanism of antimicrobial action of metronidazole.

Authors:  D I Edwards
Journal:  J Antimicrob Chemother       Date:  1979-09       Impact factor: 5.790

Review 6.  Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.

Authors:  K C Lamp; C D Freeman; N E Klutman; M K Lacy
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

7.  Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women.

Authors:  Patricia Kissinger; W Evan Secor; Jami S Leichliter; Rebecca A Clark; Norine Schmidt; Erink Curtin; David H Martin
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079

8.  Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial.

Authors:  Patricia Kissinger; Christina A Muzny; Leandro A Mena; Rebecca A Lillis; Jane R Schwebke; Laura Beauchamps; Stephanie N Taylor; Norine Schmidt; Leann Myers; Peter Augostini; William E Secor; Martina Bradic; Jane M Carlton; David H Martin
Journal:  Lancet Infect Dis       Date:  2018-10-05       Impact factor: 25.071

9.  Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009-2010.

Authors:  Robert D Kirkcaldy; Peter Augostini; Lenore E Asbel; Kyle T Bernstein; Roxanne P Kerani; Christie J Mettenbrink; Preeti Pathela; Jane R Schwebke; W Evan Secor; Kimberly A Workowski; Darlene Davis; Jim Braxton; Hillard S Weinstock
Journal:  Emerg Infect Dis       Date:  2012-06       Impact factor: 6.883

Review 10.  Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting.

Authors:  Lori Newman; Jane Rowley; Stephen Vander Hoorn; Nalinka Saman Wijesooriya; Magnus Unemo; Nicola Low; Gretchen Stevens; Sami Gottlieb; James Kiarie; Marleen Temmerman
Journal:  PLoS One       Date:  2015-12-08       Impact factor: 3.240
  10 in total
  1 in total

1.  Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.

Authors:  Patricia J Kissinger; Charlotte A Gaydos; Arlene C Seña; R Scott McClelland; David Soper; W Evan Secor; Davey Legendre; Kimberly A Workowski; Christina A Muzny
Journal:  Clin Infect Dis       Date:  2022-04-13       Impact factor: 20.999
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.